- ‘ Gyrus Inc, Maple Grove, MN JUL 2 1 2003 510(k) Premarket Notification
March 28, 2003 Gyrus PlasmaKinetic Superpulse Generator System &
Accessories

KO31085
510(k) Summary of Safety and Effectiveness
Gyrus PlasmaKinetic Superpulse System (Generator & Accessories)
Submitted by: Gyrus Inc
6655 Wedgwood Road Suite 105
Maple Grove
Minnesota 55311
Contact Person: Mercedes Bayani
Director Regulatory Affairs and Clinical
Telephone: (763) 416-3015
Facsimile: (763) 416-3070
Date Summary Prepared: 2003
Name of the Device:
Proprietary Name: Gyrus PlasmaKinetic Superpulse System (Generator & Accessories)
Project Name: Superputse
Common/Usual Name: Electrosurgical Generator and Accessories
Classification Name: Electrosurgical Cutting & Coagulation Device and
Accessories (per 21 CFR 878.4400)
Brand Name: Not yet assigned
Predicate Devices:
Gyrus Inc Plasmakinetic Generator (KO03060)
Gyrus Medical Ltd PlasmaKinetic Endourology Generator
(KO003569)
Gyrus Medical Ltd Endourology Axipolar Resectoscope
Electrode (K001270)

: . Gyrus Inc, Maple Grove, MN 510(k) Premarket Notification
March 28, 2003 Gyrus PlasmaKinetic Superpulse Generator System &
Accessories
Description: The Gyrus PlasmaKinetic Superpulse System Generator

is an Electrosurgical device with a bipolar mode of
operation:

The generator has controls for output waveform type and
power. The unit has readouts for set power and
waveform.

The two physically identical connectors on the front panel
support Plasmakinetic, Plasmakinetic Superpulse (RHS
only) and 4mm bipolar instruments. The foot pedal is
connected on the back panel.

Accessories included with the generator are the
electrodes, connector cable, footswitch and a power
cable. \

Statement of Intended Use: The Gyrus PlasmaKinetic Superpulse System is intended
for use for ablation, removal, resection and coagulation
of soft tissue and where associated hemostasis is
required
This device is intended for use by qualified medical
personnel trained in the use of electrosurgery.

Comparison to Predicate Devices: | The Gyrus PlasmakKinetic Superpulse System has been
carefully compared to legally marketed devices with
respect to intended use and technological characteristics.
\n addition, performance testing has been done to
validate the performance of the device. The comparison
and validation results presented in this 510(k) notification
to the FDA show that the device is substantially
equivalent to predicate devices and is safe and effective
in its intended use.

01,
%
i & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
"3
Food and Drug Administration
JUL 2 1 2003 Rockville MD 20850"
Ms. Mercedes Bayani
Director, Regulatory Affairs and Clinical
Gyrus, Inc.
6655 Wedgwood Road, Suite 105
Maple Grove, Minnesota 55311
Re: K031085
Trade/Device Name: Gyrus PlasmaKinetic Superpulse System (Generator & Accessories)
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI
Dated: April 3, 2003
Received: April 24, 2003
Dear Ms. Bayani:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The ‘
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Mercedes Bayani
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the
promotion and advertising of your device, please contact the Office of Compliance at (301) 5944639. Also, please note the regulation entitled, "Misbranding by reference to premarket
notification” (21CFR Part 807.97) you may obtain. Other general information on your
responsibilities under the Act may be obtained from the Division of Small Manufacturers, ©
International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597
or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

~ . q ~
Mwuen C Wevert
fo(Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
: Center for Devices and
‘ Radiological Health

Enclosure ©

Gyrus Inc, Maple Grove, MN $10(k) Premarket Notification
July 17, 2003 Gyrus PlasmaKinetic Superpulse Generator System & Accessories
Indications for Use
510(k) Number (if known): K031085
Device Name: Gyrus Plasmakinetic Superpulse System Generator
& Accessories
ELECTROSURGICAL GENERATOR
Indications For Use;
The Gyrus PlasmaKinetic Superpulse System is intended for use for ablation, removal,
resection and coagulation of soft tissue and where associated hemostasis is required in open,
endoscopic and laparoscopic surgical procedures.
The device is intended for use by qualified medical personne! trained in the use of
electrosurgical equipment.
(ivision Sign-Off)
Division of General, Restorative
and Neurological Devices
510(k) Number_1X 0.3 (OSS
: (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED) :
Concurrence of CDRH, Office of Device Evaluation (ODE) ~
Prescription Use _X OR Over-The-Counter Use
06) CFR 801.109) (Optional Format

